Block Listing Return

Oxford Biomedica PLC
02 January 2024
 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

309,426

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2,905

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

306,521






 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

442,977

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

192,609

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

250,368






 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

296,272

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

28,200

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

268,072






 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,753

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Oxford Biomedica (OXB)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today